No abstract available
MeSH terms
-
Antineoplastic Agents, Alkylating / administration & dosage
-
Antineoplastic Agents, Alkylating / therapeutic use
-
Bone Neoplasms* / diagnostic imaging
-
Bone Neoplasms* / drug therapy
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / therapeutic use
-
Fatal Outcome
-
Female
-
Hemangioendothelioma, Epithelioid* / diagnosis
-
Hemangioendothelioma, Epithelioid* / diagnostic imaging
-
Hemangioendothelioma, Epithelioid* / drug therapy
-
Hemangioendothelioma, Epithelioid* / pathology
-
Humans
-
Liver / pathology
-
Liver Neoplasms* / diagnosis
-
Liver Neoplasms* / diagnostic imaging
-
Liver Neoplasms* / drug therapy
-
Liver Neoplasms* / pathology
-
Lung / pathology
-
Lung Neoplasms* / diagnosis
-
Lung Neoplasms* / diagnostic imaging
-
Lung Neoplasms* / drug therapy
-
Lung Neoplasms* / pathology
-
Middle Aged
-
Neoplasms, Multiple Primary* / diagnosis
-
Neoplasms, Multiple Primary* / diagnostic imaging
-
Neoplasms, Multiple Primary* / drug therapy
-
Neoplasms, Multiple Primary* / pathology
-
Radiography, Abdominal
-
Radiography, Thoracic
-
Radionuclide Imaging
-
Time Factors
-
Tomography, X-Ray Computed
Substances
-
Antineoplastic Agents, Alkylating
-
Cyclophosphamide